Photo by Martin Barraud/Getty Images
April 7, 2021
Better Therapeutics, a nutritional cognitive behavioral therapy digital therapeutics company, announced plans today to go public by merging with special purpose acquisition company Mountain Crest Acquisition Corp II.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company. It includes a $50 million private investment in...
(Image: Screenshot of the Glooko.com website)
March 16, 2021
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
February 8, 2021
Fitbit users can now track their blood glucose levels within the device’s connected app, the company announced Monday in a blog post.
Users can import their blood sugar data automatically by connecting with their LifeScan OneTouch Reveal app or by manually logging their levels. Fitbit will be adding other glucose meters and apps in the future, it said in the announcement.
Within the Fitbit app,...
February 2, 2021
Onduo Health, the virtual diabetes coaching program backed by Verily (and to a lesser extent Sanofi), announced this morning that it is expanding its platform beyond Type 2 diabetes to include several other conditions frequent among its populations.
Multi-condition services focused on hypertension, pre-diabetes, weight loss and mental wellbeing – as well as underlying coaching support for dieting...
The InPen alongside Companion Medical's connected app
November 12, 2020
Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) system.
Of note, Medtronic's InPen is the only smart insulin pen cleared by the FDA for use by people requiring multiple daily injections. It received that 510(k) back in 2016.
WHY IT MATTERS
September 16, 2020
Taiwan-based digital health startup Health2Sync has entered into a partnership with pharma giant Sanofi with the aim to apply the digital solution provided by Health2Sync in 300 clinics and hospitals nationwide certified by Taiwan Diabetes Shared Care Network over the next three years.
As part of the partnership, Health2Sync will provide patient management software for healthcare professionals...
August 24, 2020
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
August 18, 2020
Cecelia Health, a virtual diabetes and chronic disease management startup, has raised $13 million in Series B funding. Rittenhouse Ventures and Endo Investors co-led the round, which also saw participation from Boston Millennia Partners, SustainVC, G100 Capital and others.
WHAT IT DOES
The company was initially founded as Fit4D, and focused on access to certified diabetes educators (CDE) for...
August 11, 2020
Continuous glucose monitoring (CGM) system-maker Senseonics has cut a deal with Ascensia Diabetes Care and its parent company, PHC Holdings, outlining commercialization and distribution of the Eversense product line over the next few years.
According to the companies, Ascensia now holds exclusive global distribution rights for the Eversense, Eversense XL and future CGMs. The duration of the...
July 29, 2020
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...